BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Sirona Biochem Engages Global Beauty Consulting

  Sirona Biochem Corp. has announced its partnership with Global Beauty Consulting – Cosmetics Laboratory, under the leadership of CEO Gaël Boutry, a distinguished French formulator.

  February 15, 2024

   · 

  3 min read
• Pharm Country

  Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference

  The Muscular Dystrophy Association announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific Conference, where she will address the world’s leaders in neuromuscular disease research and care.

  February 15, 2024

   · 

  3 min read
• BioCapital

  BioElectronics Chairman Updates Investors

  BioElectronics Corporation releases an update from its Chairman, Richard Staelin, PhD.

  February 15, 2024

   · 

  8 min read
• Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

  Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies

  February 15, 2024

   · 

  6 min read
• Policy

  Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System

  Merit Medical Systems, Inc., a global leader of healthcare technology, has received US Food and Drug Administration 501 clearance for the SCOUT® MD™ Surgical Guidance System.

  February 15, 2024

   · 

  3 min read
• Pharm Country

  Tevogen Bio Announces $8 Million Equity Investment

  On February 14, 2024, Tevogen Bio Holdings Inc. entered into a securities purchase agreement with an investor pursuant to which the investor agreed to purchase shares of Series A Preferred Stock of the Company for an aggregate purchase price of $8.0 million.

  February 15, 2024

   · 

  6 min read
• BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

  BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists

  February 15, 2024

   · 

  6 min read
• Business

  OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer

  OnKure, Inc. announced the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer. Dr. Agresta brings more than 15 years of leadership experience in global, oncology drug development from IND to Phase 4 design and execution, approval, medical and regulatory affairs strategic planning.

  February 15, 2024

   · 

  2 min read
• Drug Development

  NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury

  February 15, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage

  February 15, 2024

   · 

  10 min read
• Bio NC

  Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day

  Pfizer Inc. invites investors and the general public to access a live video webcast of its Oncology Innovation Day on Thursday, February 29, 2024, from 1:00 p.m. EST to 5:30 p.m. EST, with an approximately 20-minute break at the midpoint.

  February 15, 2024

   · 

  4 min read